Going Private • Healthcare Services

ArchiMed Acquires Bomi Group

On March 1, 2019, private equity firm ArchiMed acquired healthcare services company Bomi Group for 70M EUR

Acquisition Context
  • This is ArchiMed’s 3rd transaction in the Healthcare Services sector.
  • This is ArchiMed’s 4th largest (disclosed) transaction.
  • This is ArchiMed’s 4th transaction in Italy.
Investment Fate
  • Bomi Group was sold to a publicly-traded strategic buyer in 2022.

Explore All 51 Going Private Healthcare Services Deals - Search the Database Free


M&A Deal Summary

Date March 1, 2019
Target Bomi Group
Sector Healthcare Services
Buyer(s) ArchiMed
Deal Type Going Private
Deal Value 70M EUR
Advisor(s) Simmons & Simmons (Legal)

Target Company

Bomi Group

Spino d’Adda, Italy
Bomi Group runs cutting-edge transport, warehousing, and supply chain management services for healthcare companies ranging from pharmaceutical and medical equipment manufacturers to hospitals, testing laboratories, and outpatient service providers. Bomi Group was formed in `1985 and is based in Spino d’Adda, Italy.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

ArchiMed

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2014
PE ASSETS 8.0B EUR
Size Mega
Type Sector Focused
DESCRIPTION

ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €10 million to €1 billion per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.


Deal Context for Buyer #
Overall 13 of 38
Sector: Healthcare Services 3 of 4
Type: Going Private 1 of 4
Country: Italy 4 of 6
Year: 2019 1 of 4
Size (of disclosed) 4 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-11-22 Clean Biologics

Montaigu, France

Clean Biologics is a biopharmaceutical services company specializing in the viral and biological safety of biopharmaceuticals including recombinant proteins, therapeutic antibodies, vaccines, cell and gene therapies, and phage therapy. Clean Biologics was founded in 2000 and is based in Montaigu, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-05-13 Duomodiag

France

Duomodiag is a holding company.

Buy -